Kiplinger Dividend 15: CVS Interrupts Its String of Hikes
After raising its payout for 14 years straight, the pharmacy ended its streak in 2018.

Since we last updated the Kiplinger Dividend 15, the list of our favorite dividend-paying stocks, volatility has ruled the market. Despite the ups and downs, Standard & Poor’s 500-stock index has returned 11.9%, including dividends, since we launched the Dividend 15 in our December issue. By comparison, our collection returned an average of 5.4%. Of course, these stocks were chosen for their stable payouts, income growth or above-average yields, not their ability to outpace the market. (Prices and returns are through June 15.)
That said, a handful of the Dividend 15 beat the S&P 500. Texas Instruments (TXN) returned 31.6%, thanks to strong demand for its chips. Home Depot, helped by a strong housing market, returned 24.6%. Shares in Emerson Electric, which makes electrical and electronic products, have returned 17.5%. And Enterprise Products Partners, which runs oil and gas pipelines, posted a 12.9% gain.
Still, two consumer-products giants have been a drag on the group. Johnson & Johnson (JNJ) shares fell 3.8%, and Procter & Gamble dropped 12.8%. But we’re upbeat about the pair with regard to both their dividends and their solid prospects overall. Johnson & Johnson raised its quarterly payout by 7% in April. The company, says CFRA analyst Jeffrey Loo, has “unmatched depth and breadth in growing global health care markets and solid positions in drugs, medical devices and consumer products.” Procter & Gamble (PG) lifted its quarterly dividend by 4% in April, and analysts expect the company to report 7% earnings growth in 2018.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
A Long Streak Ends
CVS Health (CVS) was a laggard, too. The stock sank 12.0%. What’s more, despite expectations that the firm would continue its history of robust dividend hikes, it did not raise its payout for 2018, ending a 14-year record of consecutive annual increases. Analysts say a freeze of the dividend at current levels is a possibility following CVS’s deal to buy insurer Aetna for $69 billion. The merger, okayed by shareholders, still needs regulatory approval. If it goes through, a broader customer base will make CVS more competitive, says Value Line analyst Andre J. Costanza. And if regulators nix the deal, CVS should still deliver solid results. We’re keeping CVS in the Dividend 15 for now, but we are watching its dividend policy. Our other dividend growers are on track: Home Depot, Lockheed Martin and Texas Instruments have increased their annual payouts by double-digit percentages over their most recent fiscal years.
That brings us to Realty Income (O). Rising interest rates have put pressure on real estate investment trusts. Borrowing to buy new properties has become harder for REIT managers, and other investments’ yields have become more competitive. Since we launched the Dividend 15, Realty Income shares have lost 4.3%, while the S&P 500 Real Estate sector index was flat. Even so, Realty Income’s business is humming along. Revenue for the quarter ended in March rose 7% from the same quarter a year ago, and funds from operations (a profit measure roughly equivalent to earnings) climbed 20%. Plus, Realty Income yields 5%, more than the typical REIT yield of 4.1%.

Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
-
Should I Trade Stocks or Options?
Answering the question "should I trade stocks or options" will depend on your own risk tolerance, investing objectives and understanding of market dynamics.
By Jared Hoffmann Published
-
This Is How You Can Be a Snowbird in Retirement
There’s a lot to consider, and warm weather shouldn’t be the only deciding factor. For instance, will you rent or buy? What’s the tax and health care situation?
By Tony Drake, CFP®, Investment Advisor Representative Published
-
Stock Market Today: Stocks Lose Steam as Fed Hangover Lingers
Stocks attempted to bounce back from recent Fed-induced losses Friday, but struggled to stay higher through the close.
By Karee Venema Published
-
Stock Market Today: Stocks Head South as Treasury Yields Hit New Highs
Expectations for another potential rate hike sent yields on both the 2-year and 10-year Treasury bonds to their highest levels in almost two decades.
By Karee Venema Published
-
Stocks Close Lower After Hawkish Fed Pause
The major indexes finished in the red after the Federal Reserve kept interest rates unchanged, but left open the possibility of one more rate hike.
By Karee Venema Published
-
Stock Market Today: Stocks Drop Ahead of Fed Announcement, Klaviyo IPO
Instacart's successful IPO stood out in an otherwise down day on Wall Street.
By Karee Venema Published
-
Stock Market Today: Stocks Close Flat With Fed Meeting in Focus
A choppy session for stocks turned into a flat finish as investors looked ahead to Wednesday's Fed announcement.
By Karee Venema Published
-
Stock Market Today: UAW Strike Sends Stocks Lower
The main benchmarks ended the week with a thud as contract negotiations between the Big 3 automakers and the United Auto Workers stalled.
By Karee Venema Published
-
Stock Market Today: Stocks Rise After PPI Report, Arm IPO
The main indexes closed comfortably higher, while Arm stock soared on its first day of trading.
By Karee Venema Published
-
Stock Market Today: Markets Close Mixed on Inflation Data
August's inflation reading keeps the Fed on course to leave interest rates unchanged at its next meeting.
By Dan Burrows Published